NeurotechMagProGet access
News & Press

BrainCo Plans Wearable Brain Stimulation Device for Obesity as a Non-Drug Alternative to GLP-1s

Bloomberg (via Yahoo Finance)11/3/2026ยท17d ago๐ŸŒ Asia

Summary

Bloomberg reports that Hangzhou-based BrainCo is developing a wearable device that it says could suppress appetite by stimulating the brain, positioned as a non-drug alternative to GLP-1 treatments such as Wegovy and Zepbound. A founding partner described it as an electronic version of those drugs. The company aims to reach the market in two to three years, launching in China first and possibly the US later. No clinical trial or data was described, and the company declined to discuss fundraising or IPO plans, though Bloomberg reported in January that it had filed confidentially for a Hong Kong listing. BrainCo currently sells brain-computer interface headsets for autism, ADHD and insomnia, along with prosthetic hands, and says it may pursue invasive implants in the future.

Why it matters

It shows a non-invasive neurotech company aiming at the large obesity market that GLP-1 drugs opened. The approach is a plan with no published evidence, so efficacy and timelines are the company's claims.

#Neuromodulation#BCI

Want the full NeurotechMag Pro intelligence database?

Access 800+ papers, trials, patents, funding rounds and news items โ€” updated daily.

Start free trial
Already a member? Sign in